Quality assurance unit for the HPV type 16 vaccine trial in costa rica

Ended Definitive Contract Awarded Last action

Contract number
00261200112D261021003
Awardee
Awarding agency
Obligated
$5,432,686

Award facts

Contract value 11% obligated
$50,390,368.00 Current and potential, with all options
Completion date 100% complete
Current and potential, with all options
NAICS code
Not on record
Set-aside
No set-aside
Competition
Full and Open Competition · 1 offer
Pricing
Cost Plus Fixed Fee
Place of performance
Rockville, MD 20850, USA

Award details come from SAM.gov/FPDS.

Transactions

Action Obligated Date
Other Administrative Action 24 -$946
Funding Only Action 23 $100,806
Other Administrative Action 22 -$27,986
Other Administrative Action 21 -$6,201
Other Administrative Action 20 -$1
Other Administrative Action 19 $0
Other Administrative Action 18 -$1
Funding Only Action 17 $95,000
Funding Only Action 16 · The purpose of this modification is to provide FY 2006, 2007, 2008, 2009, and 2011 funds to cover indirect rate adjustments and update article B.2. For an… $21,098
Exercise an Option 15 $592,497
Funding Only Action 14 $80,000
Other Administrative Action 13 $522,437
Supplemental Agreement for work within scope 12 $190,000
Funding Only Action 11 $499,944
Other Administrative Action 10 $0
Funding Only Action 9 $440,633
Funding Only Action 8 $94,824
Funding Only Action 7 $97,672
Funding Only Action 6 $257,869
Funding Only Action 5 $500,000
Additional Work (new agreement, FAR part 6 applies) 4 $1,221,701
Other Administrative Action 3 $0
Supplemental Agreement for work within scope 2 $377,339
Original award $376,000
Show all 24

About this award

Written by GovTribe AI ·

This is a definitive contract awarded by the National Cancer Institute (NCI), a civilian agency within the U.S. Department of Health and Human Services, to Westat, Inc., a prominent professional services firm. The contract is for a "QUALITY ASSURANCE UNIT FOR THE HPV TYPE 16 VACCINE TRIAL IN COSTA RICA" with a ceiling value of $50,390,368.00. The contract is a Cost Plus Fixed Fee arrangement with an ultimate completion date of October 31, 2011. Westat has extensive experience providing research, technical assistance, and program support services to federal agencies, particularly in public health and clinical trials. The contract does not have a set-aside designation. Westat also holds several significant Indefinite Delivery Vehicles (IDVs) with the NCI and other federal agencies, demonstrating the company's capacity to provide comprehensive, long-term support across various research and program evaluation initiatives.

Quick answers

Who was awarded contract 00261200112D261021003?

00261200112D261021003 was awarded to Westat, Inc. by National Cancer Institute (National Institutes of Health) on December 15, 2001.

How much is contract 00261200112D261021003 worth?

The government has obligated $5,432,686 on 00261200112D261021003. Its current value, with exercised options, is $50,390,368.

Was contract 00261200112D261021003 competed?

The extent of competition for 00261200112D261021003 was full and open competition. The government received 1 offer.

On GovTribe

See this award's full record

  • Every transaction and funding action
  • The awardee's other awards and teaming partners
  • Similar awards and recompete opportunities
  • Ask GovTribe AI about this award
Try for free Login